MIL •
Healthcare •
Drug Manufacturers - General •
Quote as of 09/11/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeMIL
Market Capitalization396,541 mln
Float1,589 mln
Earnings Date10/30/2026
EPS
3.06
Stretched
P / E
71.54
Richly valued
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.5
Borderline
Relative Strength
20
/ 100
Significantly lagging
Debt / Equity
-11.93
Negative equity
Business Description
AbbVie is a global pharmaceutical company that develops, manufactures, and sells a wide range of medicines and therapies across multiple health areas. Its portfolio covers treatments for conditions including blood cancers, autoimmune and inflammatory diseases, neurological disorders, migraines, eye conditions, and digestive issues, among others. The company also operates in the aesthetics space, offering cosmetic injectables, skincare, and body contouring products. Founded in 2012 and based in North Chicago, Illinois, AbbVie serves patients in markets around the world.
